943 results on '"CORINALDESI R."'
Search Results
152. [Comparison of methods: gastro-duodenal manometry and study of gastric emptying]
153. Famotidine vs ranitidine h.s. in acute duodenal ulcer. A multicentre endoscopic trial
154. EXHALED BREATH ANALYSIS IN CHRONIC PANCREATITIS
155. THE QUALITY OF LIFE IN PATIENTS WITH CHRONIC PANCREATITIS EVALUATED USING THE SF-12 QUESTIONNAIRE: A COMPARATIVE STUDY WITH THE SF-36 QUESTIONNAIRE
156. Lubrication during colonoscopy: A forgotten factor
157. Functional gastrointestinal disorders and mast cells: implications for therapy
158. Oil-Lubricated Colonoscopy: Easier and Less Painful?
159. Serum Trypsinogen Activation Peptide in the Assessment of the Diagnosis and Severity of Acute Pancreatic Damage
160. QUALITY OF LIFE IN PATIENTS WITH CHRONIC PANCREATITIS.
161. Acute pancreatitis due to simvastatin therapy: increased severity after rechallenge
162. Abnormalities of somatic peptide-containing nerves supplying the pelvic floor of women with genitourinary prolapse and stress urinary incontinence
163. Endoscopic Signs in Celiac Disease
164. 11 OP Trafficking of galanin receptor 1 and 2 in HEK293 transfected cells
165. 23 OC Successfull endoscopic argon plasma treatment of the watermelon stomach
166. 2 OP Acute pancreatitis: Enhancement of early phase lymphocyte activation
167. 4 P Endoscopic evidence of gastrointestinal haemorrhage induced by 5-fluorouracil
168. 28 P Is flat adenoma a rare finding of colo-rectal mucosa?
169. 17 PS The role of magnetic endoscopic imaging on colonoscopy: Results of a prospective randomized study
170. 7 PS Type 1 anti-neuronal nuclear antibodies (ANNA-1) induce neuronal apoptosis through APAF-1 and CASPASE-3 activation in SH-SY5Y cells
171. 9 PS Protease-activated receptor-2 (PAR-2) and mast cell tryptase in irritable bowel syndrome
172. Dyspepsia and dyspepsia subgroups. Not all roads lead to Rome
173. Celiac disease: improving the diagnosis
174. Clinical Findings and Anti-Neuronal Antibodies in Coeliac Disease with Neurological Disorders
175. The pharmacological treatment of acute colonic pseudo-obstruction
176. First report on the role of magnetic endoscopic imaging (MEI)in routine colonoscopy performance
177. Intestinal neuro-immune interactions in irritable bowel syndrome are gender dependent
178. Role of scintigraphic labeling techniques in the relationship between 13C-acid octanoic breath test and scintigraphy for studying gastric emptying
179. Immunological features of idiopathic myenteric ganglionitis associated with severe gastrointestinal motor abnormalities
180. Gastric antral distension and symptoms evaluation induced by a water load test in healthy subjects and patients with functional dyspepsia
181. Helicobacter pylori , mucosal inflammation and symptom perception - new insights into an old hypothesis
182. Patients with functional gastroduodenal disorders classified by predominant symptoms according to the Rome II criteria, have different characteristics and gastric emptying
183. Role of nitric oxide- and vasoactive intestinal polypeptide-containing neurones in human gastric fundus strip relaxations
184. Tachykinin NK1receptor-mediated inhibitory responses in the guinea-pig small intestine
185. Unsuccessful Octreotide Treatment of the Watermelon Stomach
186. Changes in calcitonin gene-related peptide (CGRP) and substance P/tachykinin (SP/TK) immunoreactivity (IR) in sensory nerves of rats chronically infected with H. pylori (HP)
187. Treatment of gastro-entero-pancreatic (GEP) neuroendocrine tumors with lanreotide, a new-long-acting somatostatin analogue
188. Morpho-functional evidence for tachykinins as major non-cholinergic excitatory transmitters in the guinea pig common bile duct (CBD)
189. Diagnostic value of a validated questionnaire for dyspepsia
190. Small bowel motility and natural history of chronic intestinal pseudo-obstruction
191. Relationship between postrandial symptoms and gastric emptying in functional dyspepsia
192. Prospective Screening of Dyspeptic Patients by Helicobacter pylori Serology: A Safe Policy?
193. Symptoms and gastric functions in dyspepsia – goodbye to gastroparesis or to inadequate studies?
194. Malignancies
195. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia
196. Functional, biochemical and anatomical changes in the rat urinary bladder induced by perigangliar injection of colchicine
197. Week-end therapy for H. pylori (HP) eradication
198. Effects of Dietary Fat on Postprandial Gastrointestinal Motility Are Inhibited by a Cholecystokinin Type A Receptor Antagonist
199. Pancreatic Exocrine Carcinoma Producing Adrenocorticotropic Hormone
200. Fasting and postprandial gastrointestinal motility in ulcer and non-ulcer dyspepsia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.